MOgene LC, a genomics service provider to agricultural, pharmaceutical, food and industrial markets, located at BRDG Park, has recently added several new services to further expand their offerings. Most recently they have added Illumina NextSeq 500 which performs whole-genome, exome, and transcriptome sequencing and is flexible, offering tunable read length and multiple output configurations which offers researchers another option for high quality results in a fraction of the time of other sequencing methods.
In addition to seeing significant annual growth in core business of gene sequencing, they have also increased their staff in last several months and have plans to expand their current space at BRDG Park.
March 8, 2012: MOgene moved to BRDG Park for a bigger, customized space with resources to promote the company’s growth in the genomics industry.
“Our 5,000 square foot facility at BRDG Park has been customized to support our company’s needs, with future growth in mind,” said Shaukat Rangwala, MOgene senior vice president of operations. “BRDG Park’s management team is also steeped in the business of building life science companies like ours. Their experience, combined with BRDG Park’s unique resources and diverse list of tenants that we are eager to work with, provides the perfect springboard for our company’s growth.”
March 22, 2012: MOgene announced the signing of an agreement with Lawrence Livermore National Laboratory (LLNL) to provide services using the Lawrence Livermore Microbial Detection Array (LLMDA).
January 29, 2013: MOgene announced a partnership with fellow BRDG Park tenant, Intuitive Genomics to further expand its bioinformatics capabilities.
September 25, 2013: MOgene Green Chemicals LLC (MGC), a wholly owned subsidiary of MOgene was selected for a two-year, $1.5 million grant from the U.S. Department of Energy’s Advanced Research Project Agency – Energy (ARPA-E) to develop a technology that will convert natural gas into energy-dense transportation fuel at a more affordable cost.
“We are very pleased to receive the ARPA-E funding,” said Dr. Abhay Singh, who is leading the MGC and is serving as the principal investigator of the project. “Our technology will capture the ever expanding pool of natural gas resources within and outside of North America and transform them into transportation fuel. There is also an opportunity to capture stranded gas or bionatural gas and transforming them to higher density and infrastructure compatible fuels and chemicals. Cost and yield are major barriers in transformation of natural gas and our approach provides the opportunity to do both issues.”
October 30, 2013: MOgene announced the addition of Illumina HiSeq to further expand its offerings.
“MOgene is continually striving to become a one stop shop for genomics services. Expanding our service offerings allows us to partner with our customers and provide high quality and cost effective research solutions,” stated Shaukat Rangwala, Senior Vice President for MOgene LC.
February 26, 2014: MOgene announced it has successfully completed Illumina CSPro™ certification for sequencing on HiSeq and MiSeq, gaining entry to an elite group of Illumina genomics service providers globally.
“Illumina CSPro recognizes organizations that provide customers with industry-leading data quality and service in genetic analysis,” said Karen Possemato, Illumina’s Sr. Director of Corporate Marketing. “MOgene is now a Certified Service Provider in St. Louis, Missouri able to provide MiSeq and HiSeq sequencing services using Illumina technology. Now that MOgene is a global CSPro partner, we are excited to work with them to make it easier for researchers and clinicians in the US and elsewhere to access the power of Illumina’s genetic analysis technologies.”
April 8, 2014: MOgene announced that they have added Illumina NextSeq 500 to their list of services. Illumina NextSeq 500 performs whole-genome, exome, and transcriptome sequencing and is flexible, offering tunable read length and multiple output configurations which offers researchers another option for high quality results in a fraction of the time of other sequencing methods.
For more information on other services MOgene offers, visit www.mogene.com.